NCT00936026View on ClinicalTrials.gov

Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Healthy Subjects
Interventions
DRUG

Neramexane

Drug-Drug Interaction Study

Trial Locations (1)

89231

AAIPharma Deutschland gmbH & Co. KG, Neu-Ulm

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00936026 - Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane | Biotech Hunter | Biotech Hunter